Home >> Tag Archives: OvaGene Oncology—

Tag Archives: OvaGene Oncology—

OvaGene, Hitachi Chemical to collaborate, 12/14

December 2014—OvaGene Oncology announced it has entered into a research and development collaboration with Hitachi Chemical Research Center to bring novel mRNA-based signatures to the gynecologic oncology market. The collaboration is founded on Hitachi Chemical’s patented exosome technologies and OvaGene’s research, clinical validation, and translational focus.

Read More »